The University of Chicago Header Logo

Connection

Mark Kozloff to Peritoneal Neoplasms

Back to Details
This is a "connection" page, showing publications Mark Kozloff has written about Peritoneal Neoplasms.
Mark Kozloff
Connection Strength
0.025
Peritoneal Neoplasms
  1. Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol. 2005 Nov 01; 23(31):8033-40.
    View in: PubMed
    Score: 0.015
  2. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol. 1981; 16(3):273-7.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.